MYRIAD GENETICS INC Quarterly Depreciation in USD from Q3 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Myriad Genetics Inc quarterly/annual Depreciation history and growth rate from Q3 2014 to Q2 2024.
  • Myriad Genetics Inc Depreciation for the quarter ending June 30, 2024 was $4.6M, a 70.4% increase year-over-year.
  • Myriad Genetics Inc Depreciation for the twelve months ending June 30, 2024 was $17.2M, a 1.15% decline year-over-year.
  • Myriad Genetics Inc annual Depreciation for 2023 was $19.1M, a 64.7% increase from 2022.
  • Myriad Genetics Inc annual Depreciation for 2022 was $11.6M, a 4.13% decline from 2021.
  • Myriad Genetics Inc annual Depreciation for 2021 was $12.1M, a 10% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $17.2M $4.6M +$1.9M +70.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $15.3M $4.9M -$3.8M -43.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $19.1M $4.3M +$1.2M +38.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $17.9M $3.4M +$500K +17.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $17.4M $2.7M -$100K -3.57% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $17.5M $8.7M +$5.9M +211% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $11.6M $3.1M -$100K -3.13% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $11.7M $2.9M +$300K +11.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $11.4M $2.8M -$600K -17.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $12M $2.8M -$100K -3.45% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $12.1M $3.2M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $2.6M +$200K +8.33% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $3.4M +$900K +36% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $2.9M +$300K +11.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q3 2020 $10.5M $2.4M -$500K -17.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $11M $2.5M -$600K -19.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $11.6M $2.6M -$500K -16.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $12.1M $3M +$400K +15.4% Oct 1, 2019 Dec 31, 2019 10-Q 2020-02-07
Q3 2019 $11.7M $2.9M -$2M -40.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $13.7M $3.1M -$2.7M -46.6% Apr 1, 2019 Jun 30, 2019 10-K 2022-02-25
Q1 2019 $16.4M $3.1M -$500K -13.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $16.9M $2.6M -$1.2M -31.6% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-07
Q3 2018 $18.1M $4.9M +$1M +25.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $17.1M $5.8M +$1.8M +45% Apr 1, 2018 Jun 30, 2018 10-KT 2021-03-16
Q1 2018 $15.3M $3.6M -$100K -2.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $15.4M $3.8M +$200K +5.56% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-06
Q3 2017 $15.2M $3.9M +$200K +5.41% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $15M $4M +$600K +17.6% Apr 1, 2017 Jun 30, 2017 10-K 2019-08-13
Q1 2017 $14.4M $3.7M +$200K +5.71% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $14.2M $3.6M $0 0% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q3 2016 $14.2M $3.7M +$100K +2.78% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $14.1M $3.4M -$100K -2.86% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-24
Q1 2016 $14.2M $3.5M +$200K +6.06% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $14M $3.6M +$700K +24.1% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-08
Q3 2015 $13.3M $3.6M +$1M +38.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $12.3M $3.5M Apr 1, 2015 Jun 30, 2015 10-K 2017-08-09
Q1 2015 $3.3M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $2.9M Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-03
Q3 2014 $2.6M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.